Delivery Order SPE2DB20D2104-SPE2DB25FMXNG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) with a ceiling value of $18,278.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Epinephrine 0.15 mg auto-injector 2-packs with a ceiling value of $10,174.38 and firm fixed pricing. The order, which is not a set-aside contract, is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with a ceiling value of $1,128.69. This competitive, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $3,401.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $1,701.70. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for ultimate completion by July 30, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack configuration) with a ceiling value of $1,076.82. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack) with a ceiling value of $1,972.71 and a firm fixed price structure. This delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The contract specifies...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $8,428.38. This firm fixed-price delivery order, which is non-competitive and carries an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $3,545.04. This is a firm fixed-price delivery order with no set-aside designation, executed competitively. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of April 30, 2025. This delivery order is issued under...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXNGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) with a ceiling value of $1,308.27. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 13, 2025. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical commodities to support military and federal healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio with the Defense Logistics Agency focused on delivering medications, vaccines, medical devices, and specialized healthcare supplies across multiple therapeutic areas. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition positions it as a critical vendor for the Defense Health Agency and other government healthcare systems. This specific delivery order for epinephrine auto-injectors supports emergency medical readiness across military and federal healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/12/25 |